[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].

Nishio, Makoto; Ohe, Yuichiro; Ohashi, Kadoaki; Toyozawa, Ryo; Satouchi, Miyako; Sekine, Nobuyuki; Mori, Joji; Enatsu, Sotaro; Goto, Koichi

Nishio, Makoto; Ohe, Yuichiro; Ohashi, Kadoaki; Toyozawa, Ryo; Satouchi, Miyako; Sekine, Nobuyuki; Mori, Joji; Enatsu, Sotaro; Goto, Koichi.

Affiliation

Nishio M; Dept. of Thoracic Medical Oncology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research.

Gan To Kagaku Ryoho ; 49(6): 669-675, 2022 Jun.

Article in Ja | MEDLINE | ID: mdl-35799394

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung/drug therapy; Humans; Japan; Lung Neoplasms/drug therapy; Proto-Oncogene Proteins c-ret/analysis; Proto-Oncogene Proteins c-ret/genetics; Proto-Oncogene Proteins c-ret/therapeutic use; Pyrazoles/therapeutic use; Pyridines

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Country/Region as subject: Asia Language: Ja Journal: Gan To Kagaku Ryoho Year: 2022 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links